The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.
Method validation data for a UPLC-MS/MS method for simultaneous quantification of aspirin, its metabolite salicylic acid, and salvianolic acid B in human plasma.
Linearity and lower limits of detection and quantification for TH and TAM spiked lysed Hep G2 and PCCL3 cell extracts in 24- and 6-well plates respectively.
